Colossal Biosciences opens global HQ with 100 scientists focused on "de-extinction," using CRISPR to revive species like the ...

Scientists developed a new nanostructure that triples CRISPR’s ability to enter cells, unlocking even more power to treat ...

Turning genes on and off is like flipping a light switch, controlling whether genes in a cell are active. When a gene is ...

ZUG, Switzerland and BOSTON and SAN DIEGO and SHANGHAI, Sept. 22, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ: CRSP) ...

In a development that could help protect one of the world's most beloved agricultural commodities, a research team at Penn ...

CRISPR Therapeutics AG (CRSP) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at ...

In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $61.67, marking a +2.24% move from the previous day. The stock outpaced the S&P 500's daily gain of 0.59%. On the other hand, the ...

CRISPR Therapeutics and Sirius dose the first patient in a phase II study of SRSD107 for thromboembolic disorders in Europe.

Lithuania is rapidly growing as a leading force in the European life sciences scene, with over 400 life sciences companies in ...

Colossal Biosciences has just had a major breakthrough in its attempt to revive the dodo bird from extinction. What are the ...